[DEBUG-WINDOW 처리영역 보기]
BRIC을 시작페이지로 회원가입    로그인
BRIC농수식품
   
통합검색
배너1 배너2 스폰서배너광고 안내
오늘의 BRIC정보
모바일 BRIC RSS
트위터 페이스북
검색 뉴스레터 안내
좋은 연구문화 만들기
Bio일정
Bio일정
 
Bio일정 프리미엄(유료) 등록이란?
세미나 VOD
실험
실험
바이오 형광사진
실험의 달인들
Bio마켓
Bio마켓
BioJob
BioJob
Biojob 프리미엄(유료) 등록이란?
커뮤니티
커뮤니티
전체메뉴
대메뉴안내: 농수식품
농림성과 수산성과 식품성과 인터뷰
김지인
김지인 (Jee In Kim) 저자 이메일 보기
계명대학교 의과대학
 
조회 146  인쇄하기 주소복사 트위터 공유 페이스북 공유 
Role of the histone deacetylase inhibitor valproic acid in high-fat diet-induced hypertension via inhibition of HDAC1/angiotensin II axis

J Choi1, S Park1, T K Kwon2, S-I Sohn3, K M Park4 and J I Kim1,*

1
Department of molecular Medicine and Medical Research Center, Keimyung University School of Medicine, Daegu, Republic of Korea
2Department of Immunology and Medical Research Center, Keimyung University School of Medicine, Daegu, Republic of Korea
3Department of Neurology and Medical Research Center, Keimyung University School of Medicine, Daegu, Republic of Korea
4Department of Anatomy and BK21 plus, Kyungpook National University School of Medicine, Daegu, Republic of Korea

*Correspondence: Professor JI Kim, Department of Molecular Medicine and Medical Research Center, Keimyung University School of Medicine, 1095 Dalgubeol-Daero, Dalseo-Gu, Daegu 42601, Republic of Korea.

Abstract
BACKGROUND: Obesity is known as an epidemic worldwide because of consumption of westernized high-fat diets and one of the major risk factors of hypertension. Histone deacetylases (HDACs) control gene expression by regulating histone/non-histone protein deacetylation. HDAC inhibitors exert anti-cancer and anti-inflammatory effects and play a protective role in cardiovascular diseases. In the present study, we tested the effect of an FDA-approved pan-HDAC inhibitor valproic acid (VPA) on high-fat diet (HFD)-induced hypertension in mice. Further, we examined the mechanism of VPA-induced prevention of hypertension.

METHODS: Nine-week-old male C57BL/6 mice were fed either a normal diet (ND) or HFD. When the HFD group reached a pre-hypertensive phase (130-140 mm Hg systolic blood pressure), VPA was administered for 6 days (300mg·kg-1·day-1). Body weights and blood pressure (BP), expression of renin-angiotensin system (RAS) components and HDAC1 were determined. The direct role of HDAC1 in the expression of RAS components was investigated using gene silencing.

RESULTS: HFD accelerated the increase in body weight from 22.4±1.3 to 31.9±3.0 compared to in the ND group from 22.7±0.9 to 26.0±1.7 (P=0.0134 ND vs HFD), systolic BP from 118.5±5.7 to 145.0±3.0 (P<0.001), and diastolic BP from 91.0±13.6 to 121.0±5.0 (P=0.006); BP was not altered in the ND group. HFD increased RAS components and HDAC1 in the kidneys as well as leptin in the plasma. VPA administration prevented the progression of hypertension and inhibited the increase in expression of HDAC1 and RAS components. VPA did not affect plasma leptin level. Knockdown of HDAC1 in MDCK cells decreased the expression of angiotensinogen and type1 angiotensin II receptor.

CONCLUSIONS: VPA prevented HFD-induced hypertension by downregulating angiotensin II and its receptor via inhibition of HDAC1, offering a novel therapeutic option for HFD-induced hypertension.

논문정보
- 형식: Research article
- 게재일: 2017년 07월 (BRIC 등록일 2017-08-03)
- 연구진: 국내연구진 태극기
  댓글 0
등록
 
목록
한국관광공사
외부관련링크
Google scholar (by Jee In Kim)
Pubmed (by Jee In Kim)
프리미엄 Bio일정 Bio일정 프리미엄 안내
[GE APAC Fast Trak] 다운스트림 바이오프로세스 개발과정 (DEV2)
[GE APAC Fast Trak] 다운스트림 바이오프로세스 개발과정 (DEV2)
날짜: 2017.12.11~15
장소: 연수구 송도미래로 9 BRC 2동 2층 GE Healthcare APAC Fast Trak Center
4차 산업혁명 시대? 과학기술과 헌법: 헌법 제127조 제1항의 문제점 및 대안
4차 산업혁명 시대? 과학기술과 헌법: 헌법 제127조 제1항의 문제점 및 대안
날짜: 2017.11.25
장소: 고려대학교(안암) 자연계캠퍼스 하나스퀘어 강당 (B112호)
미래의학 국제포럼 : 심장/당뇨/암 질환의 바이오치료법 (International Forum on Medical Innovation of Cell & Bio Therapy) 개최
미래의학 국제포럼 : 심장/당뇨/암 질환의 바이오치료법 (International Forum on Medical Innovation of Cell & Bio Therapy) 개최
사전접수: ~2017.11.17
날짜: 2017.11.24
장소: 서울대학교병원 의생명연구원 1층 강당
『바이오화학(화장품) 산업의 이해』 교육 (중소·중견기업재직자 무료)
『바이오화학(화장품) 산업의 이해』 교육 (중소·중견기업재직자 무료)
날짜: 2017.11.21~22
장소: 연수구 갯벌로 12(송도동) 인천대학교 미추홀캠퍼스 B동 4층(테크노파크역 도보1분)
GMP 중급과정
GMP 중급과정
날짜: 2017.11.27~29
장소: 경기도 성남시 분당구 대왕판교로 700 코리아바이오파크 A*B동 지하1층 강당
QbD 실험계획법 과정
QbD 실험계획법 과정
날짜: 2017.12.06~09
장소: 경기도 성남시 분당구 판교역로 182 한국반도체산업협회 건물 9층
이전페이지로 돌아가기 맨위로 가기
 

BRIC 홈    BRIC 소개    회원    검색    문의/FAQ    광고    후원
Copyright © BRIC. All rights reserved. Contact member@ibric.org